Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlus500 Regulatory News (PLUS)

Share Price Information for Plus500 (PLUS)

Share Price is delayed by 15 minutes
Get Live Data
4,790.00    18.00 (0.38%)
Bid:
4,774.00
Ask:
4,778.00
Spread: 4.00 (0.084%)
Market Cap: £3.33b
PLUS Live PriceLast checked at - London Stock Exchange

Intraday Plus500 Share Chart

Update in relation to 2024 EGM

12 Jul 2024 07:00

RNS Number : 1171W
Plus500 Limited
12 July 2024
Β 

Β 

12 July 2024

Plus500 Ltd.

("Plus500", the "Company" or together with its subsidiaries the "Group")

Update in relation to 2024 Extraordinary General Meeting

Plus500, a global multi-asset fintech group operating proprietary technology-based trading platforms, today issues an update on the actions taken following the voting outcomes at its Extraordinary General Meeting ("EGM") held on 8 January 2024, in accordance with Provision 4 of the UK Corporate Governance Code (the "Code").

At the 2024 EGM, three resolutions proposed were passed with more than 20% of votes cast against. The resolutions related to the election of Ms. Anne Grim as Non-Executive Director (77.60% of votes cast were for), the election of Ms. Tami Gottlieb as Non-Executive Director and External Director (78.47%) and the election of Mr. Daniel King as Non-Executive Director and External Director (75.24%).

Since the EGM, consistent with the Company's commitment to maintaining ongoing, transparent dialogue with its shareholders, the Board has set out to engage with several key shareholders and shareholder advisory bodies, and accordingly, the Board has already put in place an engagement plan and has been approaching some of these parties.

The Company also notes that the advisory bodies previously recommended shareholders vote "For" in relation to these resolutions, and it believes such recommendations remain in the best interests of all shareholders. The Company will continue to gather feedback from the relevant shareholders in order to better understand their views in relation to the resolutions.

The Board as a whole is of the opinion that the contributions of each of the Board members elected at the EGM is of significant value to the Company, and therefore reaffirms its belief that Ms. Grim, Ms. Gottlieb and Mr. King remain highly suitable for their positions as Non-Executive Directors.

The Board will continue to take shareholders' views into consideration as part of its approach to achieving high governance standards and delivering long-term shareholder value.

In accordance with provision 4 of the Code, a final update on this matter will be included in the Company's 2024 Annual Report.

ForΒ furtherΒ details

Plus500 Ltd.

Elad Even-Chen, Chief Financial Officer

Owen Jones, Head of Investor Relations

+972 4 8189503

+44 (0) 7551 654208

ir@Plus500.com

DGA Group

James Melville-Ross

James Styles

Methuselah Tanyanyiwa

+44 (0)20 7664 5095

Plus500@dgagroup.com

Β 

About Plus500

Plus500 is a global multi-asset fintech group operating proprietary technology-based trading platforms. Plus500 offers customers a range of trading products, including OTC ("Over-the-Counter" products, namely Contracts for Difference (CFDs)), share dealing, as well as futures and options on futures.

The Group retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the Seychelles, the United States, Estonia, Japan, the UAE and the Bahamas and through its OTC product portfolio, offers more than 2,500 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group can trade its OTC products in more than 50 countries and in 30 languages. Plus500 does not permit customers located in the US to trade its OTC products.

Plus500 does not utilise cold calling techniques and does not offer binary options. Plus500's trading platforms are accessible from multiple operating systems (Windows, iOS and Android) and web browsers. Customer care is and has always been integral to Plus500, as such, OTC customers cannot be subject to negative balances. A free demo account is available on an unlimited basis for OTC trading platform users and sophisticated risk management tools are provided free of charge to manage leveraged exposure, and stop losses to help customers protect profits, while limiting capital losses.

Plus500 shares have a premium listing on the Main Market of the London Stock Exchange (symbol: PLUS) and are a constituent of the FTSE 250 index. www.plus500.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDSFIFMFELSESW
Date   Source Headline
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSPDMR Notification
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20268:06 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20261:15 pmRNSDirector/PDMR Dealing and Total Voting Rights
5th May 202612:36 pmRNSAGM Results
5th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSAppointment of Joint Corporate Broker
5th May 20267:00 amRNSAGM Trading Statement
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSQ1 2026 Trading Update
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.